5/31
10:48 am
alpmy
Manufacturing inspections down in China amid arrest fears and no access [Yahoo! Finance]
Low
Report
Manufacturing inspections down in China amid arrest fears and no access [Yahoo! Finance]
5/30
10:35 pm
alpmy
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE [Yahoo! Finance]
Low
Report
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE [Yahoo! Finance]
5/30
10:30 pm
alpmy
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE
Low
Report
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE
5/21
12:16 am
alpmy
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies [Yahoo! Finance]
Low
Report
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies [Yahoo! Finance]
5/21
12:00 am
alpmy
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies
Low
Report
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies
5/17
06:57 am
alpmy
Bayer Menopause Drug Shows Positive Result in Late-Stage Trials [BNN Bloomberg (Canada)]
Low
Report
Bayer Menopause Drug Shows Positive Result in Late-Stage Trials [BNN Bloomberg (Canada)]
5/13
08:09 am
alpmy
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]
5/8
11:47 am
alpmy
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor [Yahoo! Finance]
Low
Report
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor [Yahoo! Finance]
5/8
11:39 am
alpmy
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Low
Report
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
4/30
02:08 pm
alpmy
Announcing More Customer Expansions [Yahoo! Finance]
Low
Report
Announcing More Customer Expansions [Yahoo! Finance]
4/23
07:35 pm
alpmy
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting [Yahoo! Finance]
Low
Report
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting [Yahoo! Finance]
4/23
07:30 pm
alpmy
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Low
Report
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
4/9
11:00 am
alpmy
Invenra Inc. Announces a Strategic Research Agreement with Astellas Pharma in Therapeutic Bispecific Antibody Discovery [Yahoo! Finance]
Low
Report
Invenra Inc. Announces a Strategic Research Agreement with Astellas Pharma in Therapeutic Bispecific Antibody Discovery [Yahoo! Finance]
4/4
01:00 pm
alpmy
First-of-its-kind non-hormonal treatment option now approved in Australia to reduce hot flushes and night sweats associated with menopause
Low
Report
First-of-its-kind non-hormonal treatment option now approved in Australia to reduce hot flushes and night sweats associated with menopause
3/28
11:00 am
alpmy
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Low
Report
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
3/26
08:42 am
alpmy
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy [Yahoo! Finance]
Low
Report
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy [Yahoo! Finance]
3/26
08:30 am
alpmy
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Low
Report
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
3/26
08:12 am
alpmy
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer [Yahoo! Finance]
Low
Report
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer [Yahoo! Finance]
3/26
08:00 am
alpmy
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Low
Report
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
3/22
08:13 am
alpmy
Astellas Receives Positive CHMP Opinion for XTANDI™ in Additional Recurrent Early Prostate Cancer Treatment Setting [Yahoo! Finance]
Low
Report
Astellas Receives Positive CHMP Opinion for XTANDI™ in Additional Recurrent Early Prostate Cancer Treatment Setting [Yahoo! Finance]
3/22
08:00 am
alpmy
Astellas Receives Positive CHMP Opinion for XTANDI™ in Additional Recurrent Early Prostate Cancer Treatment Setting
Low
Report
Astellas Receives Positive CHMP Opinion for XTANDI™ in Additional Recurrent Early Prostate Cancer Treatment Setting
3/14
06:11 am
alpmy
HPE Asset Upcycling Services Selected by Astellas Pharma to Support Sustainability Commitments and Drive Network Standardization [Yahoo! Finance]
Low
Report
HPE Asset Upcycling Services Selected by Astellas Pharma to Support Sustainability Commitments and Drive Network Standardization [Yahoo! Finance]
3/11
09:00 am
alpmy
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Low
Report
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
3/5
08:50 am
alpmy
LabCentral and Astellas Launch Inaugural $500,000 "Diamond Ticket" at LabCentral 238 [Yahoo! Finance]
Low
Report
LabCentral and Astellas Launch Inaugural $500,000 "Diamond Ticket" at LabCentral 238 [Yahoo! Finance]
3/3
06:33 pm
alpmy
Astellas Initiates Phase 3 Clinical Studies of Fezolinetant for VMS Associated with Menopause in Japan [Yahoo! Finance]
Low
Report
Astellas Initiates Phase 3 Clinical Studies of Fezolinetant for VMS Associated with Menopause in Japan [Yahoo! Finance]